Pharmacogenomics and Personalized medicine is an advanced practice of medicine that implies on individual’s genetic profile to guide decisions made to the diagnosis, prevention and treatment of particular diseases to the right patient at the right time giving right therapy. There are number of personalized medicines than before in clinical pipeline across many diseases. Pharmacogenomics & Personalized medicine is advanced through data from the Human Genome Project. Biomarkers plays an important role in making use of pharmacogenomics, pharmaco proteomics for development of personalized medicine.
Related Conferences: International Conference on Molecular Biology and Stem Cells, November 19-20, 2018 at Paris, France; 12th International Conference on Cancer Stem Cells and Oncology Research, March 15-17, 2019 at Rome, Italy; 9th European Congress on Breast Cancer, Women’s health and Therapeutics, February 25-27, 2019; 2nd World Congress on Stem Cells and Regenerative Medicine, March 14-15, 2019, London, UK
Related Associations: The Biomarkers consortium, International Society for Oncology and Biomarkers, Biomarkers profile corporation, World Molecular Imaging Society, European Society of Molecular Imaging, Biomarkers Society, Society of Nuclear Medicine and Molecular Imaging
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
